Tremfya

Tremfya Description

guselkumab

Manufacturer:

Cilag AG

Distributor:

Johnson & Johnson
Full Prescribing Info
Description
Each 100 mg Pre-filled pen contains 100 mg of guselkumab per 1 mL.
Guselkumab is a fully human immunoglobulin G1 lambda (IgG1λ) monoclonal antibody (mAb) that binds selectively to the extracellular human interleukin 23 (IL-23) protein with high specificity and affinity. Guselkumab is produced in a mammalian cell line using recombinant DNA technology. Guselkumab is produced by a recombinant cell line of hamster origin using fed batch cell culture, and it is purified by a series of steps that includes measures to inactivate and remove viruses. No adjuvants are used.
Guselkumab (Tremfya) is essentially free of visible particulate material with a pH of approximately 5.8.
Guselkumab (Tremfya) does not contain preservatives.
Excipients/Inactive Ingredients: The excipients are L-histidine, L-histidine monohydrochloride monohydrate, Polysorbate 80, Sucrose and Water for injection.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in